Literature DB >> 15163704

Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase.

Paul L Boyer1, Carolyn R Stenbak, Patrick K Clark, Maxine L Linial, Stephen H Hughes.   

Abstract

Foamy virus (FV) replication, while related to that of orthoretroviruses, differs at a number of steps. Several of these differences involve the reverse transcriptase (RT). There appear to be fewer RTs present in FV than in orthoretroviruses; we previously proposed that the polymerase of FV RT was more active than orthoretroviral RTs to compensate for the numerical difference. Here we present further characterization of the RT of FV. The polymerase activity of FV RT was greater than that of human immunodeficiency virus type 1 RT in a variety of assays. We also examined the RNase H activity of FV RT, and we propose that FV RT has a basic loop in the RNase H domain. Although the sequence of the basic loop of FV RT is different from the basic loop of either Moloney leukemia virus RNase H or Escherichia coli RNase H, the FV RT basic loop appears to have a similar function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163704      PMCID: PMC416499          DOI: 10.1128/JVI.78.12.6112-6121.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Mass determination of rous sarcoma virus virions by scanning transmission electron microscopy.

Authors:  V M Vogt; M N Simon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Defects in Moloney murine leukemia virus replication caused by a reverse transcriptase mutation modeled on the structure of Escherichia coli RNase H.

Authors:  A Telesnitsky; S W Blain; S P Goff
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

3.  Determinants of the RNase H cleavage specificity of human immunodeficiency virus reverse transcriptase.

Authors:  J J DeStefano; L M Mallaber; P J Fay; R A Bambara
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus.

Authors:  G A Jamjoom; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

6.  A joint produce of the genes gag and pol of avian sarcoma virus: a possible precursor of reverse transcriptase.

Authors:  H Oppermann; J M Bishop; H E Varmus; L Levintow
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

7.  Viral polyproteins in chick embryo fibroblasts infected with avian sarcoma leukosis viruses.

Authors:  M J Hayman
Journal:  Virology       Date:  1978-03       Impact factor: 3.616

8.  Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids.

Authors:  Martin Heinkelein; Cordula Leurs; Matthias Rammling; Katrin Peters; Helmut Hanenberg; Axel Rethwilm
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.

Authors:  M Löchelt; H Zentgraf; R M Flügel
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

10.  The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.

Authors:  M Shaharabany; A Hizi
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  22 in total

1.  Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation.

Authors:  Eun-Gyung Lee; Jacqueline Roy; Dana Jackson; Patrick Clark; Paul L Boyer; Stephen H Hughes; Maxine L Linial
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

2.  RNA and protein requirements for incorporation of the Pol protein into foamy virus particles.

Authors:  Katrin Peters; Tatiana Wiktorowicz; Martin Heinkelein; Axel Rethwilm
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT.

Authors:  Paul L Boyer; Carolyn R Stenbak; David Hoberman; Maxine L Linial; Stephen H Hughes
Journal:  Virology       Date:  2007-07-12       Impact factor: 3.616

4.  The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions.

Authors:  Eun-Gyung Lee; Maxine L Linial
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

5.  HIV-1 and HIV-2 reverse transcriptases: different mechanisms of resistance to nucleoside reverse transcriptase inhibitors.

Authors:  Paul L Boyer; Patrick K Clark; Stephen H Hughes
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

6.  Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.

Authors:  Paul L Boyer; Steven J Smith; Xue Zhi Zhao; Kalyan Das; Kevin Gruber; Eddy Arnold; Terrence R Burke; Stephen H Hughes
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

Review 7.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

8.  Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.

Authors:  Angela Corona; Anna Schneider; Kristian Schweimer; Paul Rösch; Birgitta M Wöhrl; Enzo Tramontano
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

9.  Genetic characterization of simian foamy viruses infecting humans.

Authors:  Réjane Rua; Edouard Betsem; Sara Calattini; Ali Saib; Antoine Gessain
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

10.  Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases.

Authors:  Maximilian J Hartl; Florian Mayr; Axel Rethwilm; Birgitta M Wöhrl
Journal:  Retrovirology       Date:  2010-01-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.